(Q43799903)

26 November 2017

0 references

Acetylcysteine for prevention of contrast nephropathy: meta-analysis (English)

1 reference

26 November 2017

1 reference

1 reference

1 reference

1 reference

3

1 reference

26 November 2017

Fokko J van der Woude

5

object named as

Fokko J van der Woude

1 reference

26 November 2017

Rainer Birck

1

1 reference

26 November 2017

Stefan Krzossok

2

1 reference

26 November 2017

Peter Schnülle

4

1 reference

26 November 2017

Claude Braun

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

26 November 2017

1 reference

26 November 2017

volume

362

1 reference

26 November 2017

issue

9384

1 reference

26 November 2017

page(s)

598-603

1 reference

Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Acetylcysteine and contrast media nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Acetylcysteine and contrast agent-associated nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Quantitative synthesis in systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Explaining heterogeneity in meta-analysis: a comparison of methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Meta-analysis: principles and procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Hospital-acquired renal insufficiency: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Investigating and Dealing with Publication and Other Biases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

Contrast nephropathy or contrast creatininopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914189-X

7 January 2021

10.1016/S0140-6736(03)14189-X

Identifiers

DOI

1 reference

26 November 2017

1 reference